Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Follow-up of Subjects Exposed to Genetically Engineered Tumor Antigen Specific T Cell Receptors

NCT03391791 is registered in ClinicalTrials.gov with Adaptimmune as lead sponsor.

NCT NCT03391791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03391791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Follow-up of Subjects Exposed to Genetically Engineered Tumor Antigen Specific T Cell Receptors
Lead sponsor
Adaptimmune
Phase
Observational
Overall status
Terminated
Start date
February 28, 2018
Completion date
July 24, 2018
Enrollment
2 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

solid and hematological malignancies